List of analytes
Orion has signed an agreement on the sale of all shares in Orion Diagnostica Oy to an investment fund managed by Axcel Management A/S, a leading Nordic private equity investment company. The closing of the transaction is expected to take place during the second quarter of 2018.
"We are eager to partner with Axcel as we continue to execute our growth strategy” says Kaisa Tarkkanen, President of Orion Diagnostica. “Axcel is an ideal partner to support our strategy with an approach fitting well with our culture and strong commitment to delivering excellent customer solutions”, she adds.
Read Orion press release: https://www.orion.fi/en/Orion-group/media/stock-exchange-releases/2018/orion-to-sell-its-orion-diagnostica-division---due-to-the-transaction-orion-updates-its-outlook/
©2013 - 2019 Orion Diagnostica Oy, P.O.Box 83, 02101 Espoo, Finland. Tel. +358 10 309 3000